In order to understand how cadherin expression reflects EMT and differentiation status in gliomas, as well as propensity to invade and migrate, it is crucial to develop large-scale studies in low-grade to high-grade gliomas, with the concomitant evaluation of both epithelial and mesenchymal cadherins. This evidence concerns the gene CDH17 and glioma.